VENTURE CAPITAL AND PRIVATE EQUITY

Scientia’s clients operate in one of the economy’s most complex settings – the life science and biotechnology industry. Private Equity and Venture Capital firms investing in life science firms must have a diverse understanding of underlying technologies, navigating the minefields of developing a product in a highly regulated environment, managing a syndicate of investors who have very different agendas and strategies, and far more issues.

Scientia Advisors has more than 30 years of experience developing strategies needed to build successful companies at all stages of the development paradigm. Through our work with global companies, we identify pipeline and product gaps that need to be filled. We have assembled a vast network of external experts for primary research: physicians, lab managers, bio-pharma researchers and decision makers and academicians.

We approach each situation with a standardized process, but because we understand the venture/private equity mindset, we do not overanalyze. We focus on the core issues that are important in making an investment decision.

Scientia’s extensive life science and biotechnology expertise can be a trusted resource to all diversified and sector specific funds investing in the life science.

Scientia Advisors provides strategy services to both the investor (venture capital and private equity) and the portfolio firms. An example of some of the types of services we provide:

• Due Diligence
• Portfolio Strategy
• Exit Strategy

• Post Investment Growth Strategy
• Program Prioritization
• Market Strategy and Positioning
• Valuation